Bayer designates $1.5 billion for litigation over Yasmin and Yaz contraceptives
It's always important to prepare for litigation, and Bayer AG is doing just that, battening its hatches and setting aside more than $1.5 billion to cover expenses related to the wave of lawsuits the company is facing over its Yasmin and Yaz oral contraceptives.
By Julie Beck|March 04, 2013
Thank you for sharing!
Your article was successfully shared with the contacts you provided.
As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters.
Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss.
Tailored just for you. In your inbox. Every day.